PD L1 News and Research

RSS
Immunotherapy benefits patients with gastric and esophageal cancers, new data shows

Immunotherapy benefits patients with gastric and esophageal cancers, new data shows

Trial shows new first-line treatment option for patients with metastatic kidney cancer

Trial shows new first-line treatment option for patients with metastatic kidney cancer

Enhancing the efficacy of anti-PD-L1 immunotherapy for cancer

Enhancing the efficacy of anti-PD-L1 immunotherapy for cancer

LOX-1-immature neutrophils may help identify COVID-19 patients at risk of thrombosis complication

LOX-1-immature neutrophils may help identify COVID-19 patients at risk of thrombosis complication

New microgel drug delivery method could improve effectiveness of pancreatic islet transplants

New microgel drug delivery method could improve effectiveness of pancreatic islet transplants

Researchers discover how brain cancer cells evade the body's immune system

Researchers discover how brain cancer cells evade the body's immune system

New diagnostic tool can predict cancer patients' response to immunotherapy

New diagnostic tool can predict cancer patients' response to immunotherapy

Avacta expands multi-target collaboration with LG Chem Life Sciences

Avacta expands multi-target collaboration with LG Chem Life Sciences

Removing copper from blood can destroy deadliest cancers that are resistant to immunotherapy

Removing copper from blood can destroy deadliest cancers that are resistant to immunotherapy

ARDS may not be the primary lung iInjury in COVID-19

ARDS may not be the primary lung iInjury in COVID-19

Scientists identify genetic link to predict treatment response in patients with aggressive blood cancer

Scientists identify genetic link to predict treatment response in patients with aggressive blood cancer

Scientists introduce a new approach for immunological tumor treatment

Scientists introduce a new approach for immunological tumor treatment

Scientists engineer natural killer cells that target tumors and their immunosuppressive allies

Scientists engineer natural killer cells that target tumors and their immunosuppressive allies

Protein profile in serum reflects COVID-19 severity

Protein profile in serum reflects COVID-19 severity

Manipulating macrophages could be a viable strategy for treating cancer

Manipulating macrophages could be a viable strategy for treating cancer

New combination of biomarkers can benefit patients with advanced bladder cancer

New combination of biomarkers can benefit patients with advanced bladder cancer

Novel immunotherapy-plus-chemotherapy combo for pleural mesothelioma shows promise

Novel immunotherapy-plus-chemotherapy combo for pleural mesothelioma shows promise

Jane and Aatos Erkko Foundation awards 1.5 million euros to support breast cancer study

Jane and Aatos Erkko Foundation awards 1.5 million euros to support breast cancer study

Novel immunotherapy targeting myeloid immune cells reduces tumor growth

Novel immunotherapy targeting myeloid immune cells reduces tumor growth

Novel biomarkers linked to improved outcomes with immunotherapy in metastatic breast cancer

Novel biomarkers linked to improved outcomes with immunotherapy in metastatic breast cancer

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.